Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,388
Closed -$52.4K 2902
2023
Q4
$52.4K Buy
8,388
+463
+6% +$1.92K ﹤0.01% 2599
2023
Q3
$37.9K Buy
7,925
+407
+5% +$2.24K ﹤0.01% 2500
2023
Q2
$45K Buy
+7,518
New +$60.3K ﹤0.01% 2406
2023
Q1
Sell
-2,610
Closed -$32.4K 2590
2022
Q4
$32.4K Buy
2,610
+1,050
+67% +$18.4K ﹤0.01% 2217
2022
Q3
$32K Buy
+1,560
New +$43.4K ﹤0.01% 2239
2020
Q1
Sell
-1,369
Closed -$38K 1300
2019
Q4
$38K Buy
+1,369
New +$36.6K ﹤0.01% 2242
2018
Q1
Sell
-10,451
Closed -$136K 2641
2017
Q4
$136K Buy
+10,451
New +$198K ﹤0.01% 1413

Other funds holding AFMD

Two Sigma Securities's AFMD Position: Q1 2024 in Review

Two Sigma Securities sold out of Affimed (AFMD) in Q1 2024, closing a stake of 8,388 shares — an estimated $52.4K sold.

Two Sigma Securities first reported a position in AFMD in Q4 2017 and held it in 7 quarters. The position peaked at $136K in Q4 2017. 46 funds tracked by Wall St. Rank hold AFMD as of Q1 2024.

  • Two Sigma Securities reported no remaining Affimed position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 8,388 Affimed shares in Q1 2024, an estimated $52.4K.
  • Two Sigma Securities first reported a position in Affimed in Q4 2017 and held it in 7 quarters.
  • Two Sigma Securities's Affimed position peaked at $136K in Q4 2017.
  • 46 funds tracked by Wall St. Rank held Affimed as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.